{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T12:30:41Z","timestamp":1789389041950,"version":"build-2803163510"},"reference-count":98,"publisher":"Informa UK Limited","issue":"6","funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI08764301-A1"],"award-info":[{"award-number":["R01 AI08764301-A1"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007865","name":"University of Texas Medical Branch","doi-asserted-by":"publisher","award":["Funding from the Sealy Center for Vaccine Developm"],"award-info":[{"award-number":["Funding from the Sealy Center for Vaccine Developm"]}],"id":[{"id":"10.13039\/100007865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2017,6,3]]},"DOI":"10.1080\/14760584.2017.1321482","type":"journal-article","created":{"date-parts":[[2017,4,20]],"date-time":"2017-04-20T13:43:20Z","timestamp":1492695800000},"page":"601-611","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":54,"title":["Rift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate"],"prefix":"10.1080","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8318-2783","authenticated-orcid":false,"given":"Tetsuro","family":"Ikegami","sequence":"first","affiliation":[{"name":"Department of Pathology, Sealy Center for Vaccine Development, Center for Biodefense and Emerging Infectious Diseases, The University of Texas Medical Branch, Galveston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2017,5,2]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1002\/path.1700340418"},{"issue":"2","key":"cit0002","first-page":"107","volume":"29","author":"Smithburn KC","year":"1948","journal-title":"Br J Exp Pathol"},{"key":"cit0003","first-page":"1037","volume-title":"Infectious diseases of livestock with special reference to southern Africa","volume":"2004","author":"Swanepoel R","year":"2004","edition":"2"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.3390\/v3050493"},{"key":"cit0005","first-page":"403","volume-title":"Handbook series of zoonoses, section b: viral zoonoses","volume":"1","author":"Peters CJ","year":"1981"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(02)00295-9"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.3402\/iee.v5.28024"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)30401-7"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1051\/vetres\/2010033"},{"issue":"1","key":"cit0010","first-page":"1","volume":"30","author":"Smithburn KC","year":"1949","journal-title":"Br J Exp Pathol"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20624"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.3201\/eid1712.111035"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1136\/vr.109.17.383"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2014.03.008"},{"key":"cit0015","unstructured":"FAO. 2015. The last hurdles towards Rift Valley fever control. Report on the Ad hoc workshop on the current state of Rift Valley fever vaccine and diagnostics development \u2013 Rome, 5-7 March 2014. FAO Animal Production and Health Report No. 9. Rome (Italy)."},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2012.00131"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.07.046"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-66-10-2271"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02081-12"},{"issue":"7","key":"cit0020","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.2460\/ajvr.1987.48.07.1042","volume":"48","author":"Morrill JC","year":"1987","journal-title":"Am J Vet Res"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(91)90314-V"},{"issue":"10","key":"cit0022","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.2460\/ajvr.1997.58.10.1104","volume":"58","author":"Morrill JC","year":"1997","journal-title":"Am J Vet Res"},{"issue":"10","key":"cit0023","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.2460\/ajvr.1997.58.10.1110","volume":"58","author":"Morrill JC","year":"1997","journal-title":"Am J Vet Res"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.10.118"},{"issue":"1","key":"cit0025","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2460\/ajvr.1991.52.01.50","volume":"52","author":"Hubbard KA","year":"1991","journal-title":"Am J Vet Res"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1016\/0034-5288(92)90029-2"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00114-15"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00778-12"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002181"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir354"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir249"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(03)00131-2"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.12.030"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.11.078"},{"key":"cit0035","unstructured":"Hills RE. Issuance of a conditional license for Rift Valley fever vaccine, modified live virus. Notice no. 13-12. Ames (IA): Center for Veterinary Biologics; 2013."},{"key":"cit0036","unstructured":"Environmental assessment \u2013 Rift Valley fever vaccine, modified live virus (unlicensed in Canada and USA), the Canadian Centre for Veterinary Biologics (CCVB) of the Canadian Food Inspection Agency (CFIA). 2013. Available from: http:\/\/www.inspection.gc.ca\/animals\/veterinary-biologics\/licensed-products\/environmental-assessments\/rift-valley-fever-vaccine\/eng\/1393256796335\/1393256857602."},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2014.04.007"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.12.003"},{"issue":"1","key":"cit0039","first-page":"95","volume":"69","author":"Hunter P","year":"2002","journal-title":"Onderstepoort J Vet Res"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1089\/vbz.2012.1160"},{"issue":"2","key":"cit0041","first-page":"119","volume":"44","author":"Coetzer JA","year":"1977","journal-title":"Onderstepoort J Vet Res"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-6-94"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004550"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.4102\/ojvr.v82i1.857"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003550"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(99)00218-2"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.02.037"},{"key":"cit0048","unstructured":"U.S. Department of Health and Human Services FDA. Guidance for industory: toxicology grading scale for healthy adult and adolescent volunteers enrolled in preventive vaccine clinical trials. DHHS\/FDA, Washington, DC. 2007. Available from: https:\/\/www.fda.gov\/biologicsbloodvaccines\/guidancecomplianceregulatoryinformation\/guidances\/vaccines\/ucm074775.htm."},{"key":"cit0049","unstructured":"U.S. Department of Health and Human Services FDA. Approval of biological products when human efficacy studies are not ethical or feasible. DHHS\/FDA, Washington, DC. Title 21 Code of Federal Regulations, Subpart H, Section 601.90."},{"key":"cit0050","unstructured":"U.S. Department of Health and Human Services FDA. Approval based on evidence of effectiveness from studies in animals. DHHS\/FDA, Washington, DC. Title 21 Code of Federal Regulations, Subpart I, Section 314.610."},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1177\/0300985810372506"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1991.44.278"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-71-10-2307"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02448-05"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.16.8922-8926.2004"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-007-1069-z"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1089\/vbz.2015.1830"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.en.33.010188.001125"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1603\/0022-2585-38.4.480"},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.7589\/0090-3558-10.3.279"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00135-15"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2008.05.033"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(90)90096-5"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.00787"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02241-15"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.80.6.2933-2940.2006"},{"key":"cit0067","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2006.09.035"},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.2008\/002097-0"},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01238-07"},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001639"},{"key":"cit0071","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002670"},{"key":"cit0072","doi-asserted-by":"publisher","DOI":"10.1038\/emi.2014.71"},{"key":"cit0073","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.06046-11"},{"key":"cit0074","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.08.003"},{"key":"cit0075","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.12.064"},{"key":"cit0076","first-page":"1","author":"Nishiyama S","year":"2016","journal-title":"Virulence"},{"key":"cit0077","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2007.01.046"},{"key":"cit0078","doi-asserted-by":"publisher","DOI":"10.1586\/erv.12.106"},{"key":"cit0079","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000287"},{"key":"cit0080","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M008140200"},{"key":"cit0081","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.051250-0"},{"key":"cit0082","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/7346294"},{"key":"cit0083","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-8-532"},{"issue":"1","key":"cit0084","first-page":"45","volume":"48","author":"Barnard BJ","year":"1977","journal-title":"J S Afr Vet Assoc"},{"key":"cit0085","first-page":"33","volume-title":"Recognizing Rift Valley fever","author":"Davies FG","year":"2003"},{"key":"cit0086","doi-asserted-by":"publisher","DOI":"10.3201\/eid1906.121641"},{"key":"cit0087","doi-asserted-by":"publisher","DOI":"10.1089\/vbz.2010.0245"},{"key":"cit0088","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.07.037"},{"key":"cit0089","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00841-11"},{"key":"cit0090","doi-asserted-by":"publisher","DOI":"10.1038\/srep20617"},{"key":"cit0091","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-10-349"},{"key":"cit0092","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.03.061"},{"key":"cit0093","doi-asserted-by":"publisher","DOI":"10.1089\/vbz.2014.1650"},{"key":"cit0094","doi-asserted-by":"publisher","DOI":"10.1038\/srep27719"},{"key":"cit0095","doi-asserted-by":"publisher","DOI":"10.1089\/vbz.2012.1285"},{"key":"cit0096","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2012.02.017"},{"key":"cit0097","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.00651"},{"key":"cit0098","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2013.03.009"}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2017.1321482","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T23:24:20Z","timestamp":1750202660000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14760584.2017.1321482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,2]]},"references-count":98,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6,3]]}},"alternative-id":["10.1080\/14760584.2017.1321482"],"URL":"https:\/\/doi.org\/10.1080\/14760584.2017.1321482","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2016-11-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-04-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-05-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}